CBD, CBG, and CBN are three distinct cannabinoids found in the cannabis plant, each with different origins, effects, and practical uses. CBD is the most widely available and researched, commonly used for stress, discomfort, and sleep. CBG is often marketed for daytime focus and clarity. CBN is the one most associated with sleep support. Despite being grouped together on product labels, these three compounds form differently in the plant, interact with the body through different pathways, and have very different levels of scientific backing.
How Each Cannabinoid Forms
All three cannabinoids trace back to a single parent molecule called CBGA, sometimes called the “mother cannabinoid.” As the cannabis plant matures, enzymes convert CBGA into the acidic precursors of THC, CBD, and other cannabinoids. CBG is simply the decarboxylated (heat-activated) form of that original CBGA molecule, which is why most harvested cannabis contains very little CBG. The plant has already converted most of it into other compounds by the time it’s mature.
CBD forms when CBGA is converted by a specific enzyme and then exposed to heat, which strips away a carbon dioxide molecule. CBN, by contrast, doesn’t come from the plant’s own enzymatic process at all. It forms when THC breaks down through exposure to air, heat, or acidic conditions over time. Older cannabis that has been stored for a while naturally contains more CBN because its THC has slowly oxidized. This distinct origin is part of why CBN behaves differently from the other two.
CBD: The Most Studied of the Three
CBD has the largest body of research behind it and is the only one of the three with an FDA-approved pharmaceutical application, used in a prescription medication for certain types of seizures. Its effects in the body are unusually broad. Rather than binding directly to the two main cannabinoid receptors (CB1 and CB2), CBD works as a negative allosteric modulator. In plain terms, it changes the shape of these receptors slightly, which alters how your body’s own endocannabinoids interact with them. This indirect mechanism is one reason CBD doesn’t produce a high.
What makes CBD pharmacologically interesting is that its effects extend well beyond those two receptors. It influences pathways involved in inflammation, oxidative stress, pain signaling, and even blood vessel dilation. This multi-pathway activity is why CBD products are marketed for such a wide range of uses, from joint discomfort and headaches to everyday stress and sleep. Among the three cannabinoids covered here, CBD has the strongest evidence for pain and anxiety-related applications. Most people describe its effects as a general sense of calm or physical ease rather than anything dramatic.
CBG: The “Focus” Cannabinoid
CBG is far less abundant in harvested cannabis than CBD, typically making up less than 1% of the plant’s cannabinoid content. Breeders have developed high-CBG hemp strains and early-harvest techniques to capture more of it before the plant converts it into other cannabinoids, which is why CBG products have become more available in recent years.
Early research points to anti-inflammatory and neuroprotective properties. CBG has also been studied alongside other cannabinoids for its ability to reduce intraocular pressure, which is relevant to glaucoma. Users and brands most commonly associate CBG with daytime mental clarity and focus rather than relaxation, making it a popular addition to daytime supplement routines. However, the research base is still thin compared to CBD. One animal study testing CBG for chronic nerve pain found no meaningful pain relief even at very high doses, which contrasted with earlier, more optimistic findings from other research groups. The inconsistency is a reminder that CBG science is still in its early stages.
CBG does not produce intoxication. Its interaction with the endocannabinoid system appears to be milder overall, and most users report subtler effects than they notice with CBD.
CBN: The “Sleepy” Cannabinoid
CBN’s reputation as a sedative cannabinoid is its defining feature in the consumer market, but the evidence is more nuanced than the marketing suggests. Because CBN is a breakdown product of THC, it retains some mild ability to bind to cannabinoid receptors, which neither CBD nor CBG does to the same degree. This gives CBN a slightly different character. Some users report mild psychoactive effects at higher doses, though nothing close to THC.
The sedative reputation likely comes from the observation that aged cannabis, which is high in CBN, tends to feel more sedating. Research by neurologist Ethan Russo and others suggests CBN may contribute to what’s called the “entourage effect,” amplifying the sedative qualities of other cannabis compounds rather than acting as a strong sedative on its own. A study on insomnia found that CBN combined with THC and CBD improved sleep symptoms in adults, but isolating CBN’s individual contribution is difficult.
Where CBN showed more clear-cut results was in a recent animal study on chronic nerve pain. Researchers found that CBN produced significant pain relief in mice with chemotherapy-induced nerve damage, and it did so without the strong side effects associated with THC. Interestingly, female mice responded faster than males, showing pain relief at 20 minutes compared to 40 minutes. The researchers noted that CBN’s side effect profile was modest, with no catalepsy (the frozen, rigid state THC can cause), suggesting it might be better tolerated than THC for pain management. This is a single preclinical study, but it positions CBN as potentially more promising for pain than its current “sleep cannabinoid” branding implies.
Direct Comparison by Use
- Pain and inflammation: CBD has the most evidence and the broadest mechanism of action. CBN showed promise in one chronic pain model. CBG’s pain results have been inconsistent across studies.
- Sleep: CBN is most commonly chosen for evening and sleep routines, though it works best alongside other cannabinoids rather than alone. CBD at higher doses is also widely used for sleep.
- Focus and daytime use: CBG is the go-to option here. It’s not associated with drowsiness and users report a sense of mental clarity.
- Anxiety and stress: CBD has the most human research supporting its calming effects. CBG and CBN may offer mild calming properties, but neither has been studied as thoroughly for this purpose.
- Intoxication: None of the three produces a significant high. CBN has the closest relationship to THC and can cause very mild psychoactive effects at higher doses, but CBD and CBG do not.
Availability and Legal Status
All three cannabinoids are legal at the federal level when derived from hemp containing less than 0.3% THC, under the 2018 Farm Bill. State regulations vary considerably, though. Some states have created specific licensing frameworks for hemp-derived cannabinoid products, and a few have restricted certain cannabinoids or product types. Tennessee, for example, recently moved regulatory oversight of hemp-derived cannabinoid products from its agriculture department to its alcoholic beverage commission, reflecting a broader trend of states tightening oversight of these products.
CBD is by far the easiest to find, available in oils, capsules, gummies, and topicals at most pharmacies and health stores. CBG and CBN products are growing in availability but remain more of a specialty purchase, often found through online retailers or dedicated cannabis wellness brands. Because CBG is harder to produce in large quantities and CBN requires either aged plant material or synthetic conversion, both tend to cost more per milligram than CBD. Many products now combine two or all three cannabinoids in a single formula, banking on the idea that they work better together than in isolation.